- Country: India
FIR against BJP BLA over false Form-7 submissions, first in Telangana
S Balachander accused of seeking deletion of 30 electors during ongoing SIR of electoral rolls
Latest coverage
- Country: India
FIR against BJP BLA over 'false' Form-7 applications, first in Telangana
An FIR has been lodged against BJP Booth Level Agent S Balachander for allegedly filing false voter deletion requests. The complaint, initiated by an election official, triggered a police inquiry. Congress leaders claim these submissions aim to unjustly disenfranchise valid voters from the…
- Country: India
BJP BLA faces search warrant over Form 7
A court in Ballari has authorised police to search the office of BJP booth level agent T Srinivas Mothkur over a list of 7,561 voters whose names he sought to have reverified during Karnataka’s electoral roll revision, according to an officer familiar with the investigation.
- Press releases
- Country: United States
Rezolute Announces FDA Recommendation to Hold a Pre-BLA Meeting as a Precursor to Submitting a Biologics License Application (BLA) for Congenital Hyperinsulinism
The Agency reiterated its commitment to addressing the unmet need for treatment of congenital and tumor-related hyperinsulinism and to serving these patient communities
- Country: India
FIR against K'taka BJP BLA-1, officials over attempt to seek deletion of 7,561 voters in Ballari
The case has been registered against Srinivas Motkar, Ballari City Corporation corporator and BJP BLA-1, Assistant Commissioner Nandeesh, Booth Level Officer (BLO) Sumalatha, and case worker Sharanabasava, based on a complaint filed by Gowtham, a Congress Booth Level Agent (BLA) for Ward No. 23…
- Country: India
FIR against BJP BLA for ‘false’ Form 7s in Malleshwaram
- Press releases
- Country: United States
Novo provides update on the denecimig Biologics License Application (BLA) in the US
Bagsværd, Denmark, 02 October 2026 – Novo Nordisk today announced that the US Food and Drug Administration (FDA) has informed Novo that the BLA review of denecimig for the treatment of haemophilia A, with or without inhibitors in adults and children, is still ongoing. The FDA has not communicated a…